Rankings
▼
Calendar
ORIC Q1 2021 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
ORIC
ORIC Pharmaceuticals, Inc.
$1B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$17M
Net Income
-$17M
EPS (Diluted)
$-0.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$284M
Total Liabilities
$8M
Stockholders' Equity
$276M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$250,000
+100.0%
Operating Income
-$17M
-$9M
-80.3%
Net Income
-$17M
-$9M
-86.1%
← FY 2021
All Quarters
Q2 2021 →